FI922143A0 - Muscarinreceptorantagonister. - Google Patents

Muscarinreceptorantagonister.

Info

Publication number
FI922143A0
FI922143A0 FI922143A FI922143A FI922143A0 FI 922143 A0 FI922143 A0 FI 922143A0 FI 922143 A FI922143 A FI 922143A FI 922143 A FI922143 A FI 922143A FI 922143 A0 FI922143 A0 FI 922143A0
Authority
FI
Finland
Prior art keywords
muscarinreceptorantagonister
Prior art date
Application number
FI922143A
Other languages
English (en)
Finnish (fi)
Other versions
FI922143A (fi
Inventor
David Alker
Peter Edward Cross
John Edward Glyn Kemp
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI922143A publication Critical patent/FI922143A/fi
Publication of FI922143A0 publication Critical patent/FI922143A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
FI922143A 1990-09-13 1992-05-12 Muscarinreceptorantagonister. FI922143A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909020051A GB9020051D0 (en) 1990-09-13 1990-09-13 Muscarinic receptor antagonists
PCT/EP1991/001705 WO1992005172A2 (en) 1990-09-13 1991-09-09 Muscarinic receptor antagonists

Publications (2)

Publication Number Publication Date
FI922143A FI922143A (fi) 1992-05-12
FI922143A0 true FI922143A0 (fi) 1992-05-12

Family

ID=10682161

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922143A FI922143A0 (fi) 1990-09-13 1992-05-12 Muscarinreceptorantagonister.

Country Status (9)

Country Link
US (1) US5397800A (ja)
EP (1) EP0510129A1 (ja)
JP (1) JPH07119213B2 (ja)
CA (1) CA2068527A1 (ja)
FI (1) FI922143A0 (ja)
GB (1) GB9020051D0 (ja)
IE (1) IE913210A1 (ja)
PT (1) PT98929B (ja)
WO (1) WO1992005172A2 (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822945D0 (en) * 1998-10-20 1998-12-16 Isis Innovations Ltd Epibatidine analogues
US6946475B1 (en) 1999-04-07 2005-09-20 University Of Virginia Patent Foundation Anticancer calcium channel blockers
EP1165508B1 (en) * 1999-04-07 2004-06-23 The University of Virginia Patent Foundation Anticancer calcium channel blockers
DE10044905A1 (de) * 2000-09-12 2002-03-21 Merck Patent Gmbh (2-Azabicyclo[2.2.1]hept-7-yl)methanol-Derivate als nikontinische Acetylcholinrezeptor Agonisten
DE10118551A1 (de) * 2001-04-14 2002-10-17 Merck Patent Gmbh Nikotinische Acetylcholinrezeptor Liganden
AU2002345266B2 (en) 2002-07-08 2009-07-02 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
US6875774B2 (en) 2002-08-06 2005-04-05 The University Of North Carolina Aza-bridged bicyclic amine derivatives for use as novel cholinergic receptor ligands
EP1534675B1 (en) * 2002-08-23 2009-02-25 Ranbaxy Laboratories, Ltd. Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo¬3.1.0 hexane derivatives as muscarinic receptor antagonists
EP2177511A2 (en) * 2002-12-10 2010-04-21 Ranbaxy Laboratories Limited Process for preparing 3,6-disubstituted azabicyclo derivatives
US7488748B2 (en) * 2003-01-28 2009-02-10 Ranbaxy Laboratories Limited 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
US7517905B2 (en) * 2003-04-09 2009-04-14 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
BRPI0409302A (pt) * 2003-04-11 2006-04-11 Ranbaxy Lab Ltd derivados azabiciclo como antagonistas de recetores muscarìnicos, método para sua preparação e composição farmacêutica contendo os mesmos
WO2006005980A1 (en) * 2004-06-16 2006-01-19 Ranbaxy Laboratories Limited Xanthine derivatives useful as muscarinic receptor antagonists
WO2006018708A2 (en) * 2004-08-19 2006-02-23 Ranbaxy Laboratories Limited Pyrrolidine derivatives as muscarinic receptor antagonists
US20080280883A1 (en) * 2004-09-24 2008-11-13 Mohammad Salman Muscarinic Receptor Antagonists
US20090105221A1 (en) * 2004-09-29 2009-04-23 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
US20100016400A1 (en) * 2004-11-19 2010-01-21 Naresh Kumar Azabicyclic muscarinic receptor antagonists
US20100035954A1 (en) * 2004-12-15 2010-02-11 Mohammad Salman Acid addition salts of muscarinic receptor antagonists
US20080319043A1 (en) * 2005-05-03 2008-12-25 Mohammad Salman 3,6-Disubstituted Azabicyclo (3.1.0) Hexane Derivatives as Muscarinic Receptor Antagonists
RU2008119323A (ru) 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Фармацевтические композиции мускаринового рецептора
US20090010923A1 (en) * 2007-04-24 2009-01-08 University Of Maryland, Baltimore Treatment of cancer with anti-muscarinic receptor agents
MX360640B (es) 2010-03-01 2018-11-09 Tau Therapeutics Llc Star Diagnosis e imagenologia de cancer.
EP2386555A1 (en) 2010-05-13 2011-11-16 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
ITRM20110083U1 (it) 2010-05-13 2011-11-14 De La Cruz Jose Antonio Freire Piastra per la costruzione di carrelli per aeroplani
EP2592077A1 (en) 2011-11-11 2013-05-15 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
EP2592078A1 (en) 2011-11-11 2013-05-15 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
SG11201504452WA (en) 2012-12-18 2015-07-30 Almirall Sa New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activity
TWI643853B (zh) 2013-02-27 2018-12-11 阿爾米雷爾有限公司 同時具有β2腎上腺素受體促效劑和M3毒蕈鹼受體拮抗劑活性之2-氨基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽類
TWI641373B (zh) 2013-07-25 2018-11-21 阿爾米雷爾有限公司 具有蕈毒鹼受體拮抗劑和β２腎上腺素受體促效劑二者之活性的２－胺基－１－羥乙基－８－羥基喹啉－２（１Ｈ）－酮衍生物之鹽
TW201517906A (zh) 2013-07-25 2015-05-16 Almirall Sa 含有ｍａｂａ化合物和皮質類固醇之組合
TW201617343A (zh) 2014-09-26 2016-05-16 阿爾米雷爾有限公司 具有β２腎上腺素促效劑及Ｍ３蕈毒拮抗劑活性之新穎雙環衍生物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721783A (en) * 1986-01-09 1988-01-26 United Pharmaceuticals, Inc. Anti-spasmodic agents having a heterocyclic ring
US5278170A (en) * 1989-04-13 1994-01-11 Beecham Group P.L.C. Azabicylo oxime compounds
GB8911080D0 (en) * 1989-05-15 1989-06-28 Merck Sharp & Dohme Chemical process
GB9000305D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Anticholinergic agents
GB9000301D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Piperidine & pyrrolidine derivatives
US5314899A (en) * 1992-03-03 1994-05-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Epibatidine and derivatives, compositions and methods of treating pain

Also Published As

Publication number Publication date
PT98929B (pt) 1999-02-26
WO1992005172A3 (en) 1992-05-29
FI922143A (fi) 1992-05-12
CA2068527A1 (en) 1992-03-14
JPH05501887A (ja) 1993-04-08
WO1992005172A2 (en) 1992-04-02
US5397800A (en) 1995-03-14
IE913210A1 (en) 1992-02-25
EP0510129A1 (en) 1992-10-28
GB9020051D0 (en) 1990-10-24
JPH07119213B2 (ja) 1995-12-20
PT98929A (pt) 1992-07-31

Similar Documents

Publication Publication Date Title
FI911924A (fi) Pyridinderivat.
DE69112037T2 (de) Waferträger.
FI922143A (fi) Muscarinreceptorantagonister.
FI915564A (fi) Torkparti.
FI915543A (fi) Pulverinhalator.
DE69111876D1 (de) Ophthalmometer.
DE59104521D1 (de) Polkern.
FI86244B (fi) Bakugn-spisugnkombination.
FI905760A (fi) Skaer- och slipanordning foer en glasskivkant.
FI912759A0 (fi) Pyridinylpiperazinderivat.
FI911496A0 (fi) Tryckkaensligt kopieringspapper.
DE69100071D1 (de) Kaefigmutter.
DE69110728D1 (de) 8-Sulfamylmethylen-2-aminotetraline.
FI915965A0 (fi) Belaeggningskomposition foer tidningspapper.
FI901498A0 (fi) Axelsystemkonstruktion foer nyttofordon.
DE59103525D1 (de) Honmachine.
FI910496A (fi) Koerlaegeskaerm foer baotar.
DE59100113D1 (de) Rollcontainer.
DE69104797T2 (de) 2-Substituierte-1-Hydroxyindole.
NO905588L (no) Kabelutlegningsutstyr.
ES1015059Y (es) Capsula-tapa.
ES1012467Y (es) Huevera.
DE59101556D1 (de) Propellane.
ES1013194Y (es) Porta-objetos.
ES1013685Y (es) Tureno pirotecnico.

Legal Events

Date Code Title Description
FD Application lapsed